Virtus Lifesci Biotech Etf Buy Hold or Sell Recommendation

BBP Etf  USD 50.96  0.36  0.71%   
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Virtus LifeSci Biotech is 'Hold'. Macroaxis provides Virtus LifeSci buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BBP positions. The advice algorithm takes into account all of Virtus LifeSci's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Virtus LifeSci's buy or sell advice are summarized below:
Real Value
52.44
Hype Value
50.96
Market Value
50.96
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Virtus LifeSci Biotech given historical horizon and risk tolerance towards Virtus LifeSci. When Macroaxis issues a 'buy' or 'sell' recommendation for Virtus LifeSci Biotech, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Virtus LifeSci Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual funds such as Virtus and provide practical buy, sell, or hold recommendation based on investors' investing horizon and their risk tolerance towards Virtus LifeSci Biotech. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Execute Virtus LifeSci Buy or Sell Advice

The Virtus recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Virtus LifeSci Biotech. Macroaxis does not own or have any residual interests in Virtus LifeSci Biotech or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Virtus LifeSci's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Virtus LifeSciBuy Virtus LifeSci
Hold

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Responds to the marketDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

Not AvailableDetails
For the selected time horizon Virtus LifeSci Biotech has a Risk Adjusted Performance of (0.07), Jensen Alpha of (0.29), Total Risk Alpha of (0.36) and Treynor Ratio of (0.13)
Our trade recommendation tool can be used to complement Virtus LifeSci Biotech advice provided by experts. It analyzes the etf's potential to grow against your specific risk preferences and investment horizon. Please use Virtus LifeSci Biotech price to earning, beta, as well as the relationship between the Beta and five year return to make buy, hold, or sell decision on Virtus LifeSci.

Virtus LifeSci Trading Alerts and Improvement Suggestions

Virtus LifeSci generated a negative expected return over the last 90 days
Latest headline from news.google.com: Looking for ETFs to Play the Artificial Intelligence Boom - AOL
The fund generated three year return of -1.0%
Virtus LifeSci Biotech holds 98.73% of its assets under management (AUM) in equities

Virtus LifeSci Returns Distribution Density

The distribution of Virtus LifeSci's historical returns is an attempt to chart the uncertainty of Virtus LifeSci's future price movements. The chart of the probability distribution of Virtus LifeSci daily returns describes the distribution of returns around its average expected value. We use Virtus LifeSci Biotech price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Virtus LifeSci returns is essential to provide solid investment advice for Virtus LifeSci.
Mean Return
-0.17
Value At Risk
-2.57
Potential Upside
1.86
Standard Deviation
1.43
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Virtus LifeSci historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Virtus LifeSci Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Virtus LifeSci or Virtus sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Virtus LifeSci's price will be affected by overall etf market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Virtus etf's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-0.29
β
Beta against NYSE Composite1.39
σ
Overall volatility
1.45
Ir
Information ratio -0.18

Virtus LifeSci Volatility Alert

Virtus LifeSci Biotech exhibits very low volatility with skewness of -0.08 and kurtosis of -0.52. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Virtus LifeSci's etf risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Virtus LifeSci's etf price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Virtus LifeSci Fundamentals Vs Peers

Comparing Virtus LifeSci's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Virtus LifeSci's direct or indirect competition across all of the common fundamentals between Virtus LifeSci and the related equities. This way, we can detect undervalued stocks with similar characteristics as Virtus LifeSci or determine the etfs which would be an excellent addition to an existing portfolio. Peer analysis of Virtus LifeSci's fundamental indicators could also be used in its relative valuation, which is a method of valuing Virtus LifeSci by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Virtus LifeSci to competition
FundamentalsVirtus LifeSciPeer Average
Price To Earning18.03 X3.15 X
Price To Book1.66 X0.39 X
Price To Sales5.60 X0.33 X
Beta0.65
One Year Return(1.50) %(0.97) %
Three Year Return(0.70) %3.23 %
Five Year Return4.30 %1.12 %
Net Asset15.87 M2.29 B
Equity Positions Weight98.73 %52.82 %

Virtus LifeSci Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Virtus . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Virtus LifeSci Buy or Sell Advice

When is the right time to buy or sell Virtus LifeSci Biotech? Buying financial instruments such as Virtus Etf isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Virtus LifeSci in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Investor Favorites Thematic Idea Now

Investor Favorites
Investor Favorites Theme
Macroaxis most traded equities with largest long positions over the last 2 years. The Investor Favorites theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investor Favorites Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Virtus LifeSci Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Virtus Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Virtus Lifesci Biotech Etf. Highlighted below are key reports to facilitate an investment decision about Virtus Lifesci Biotech Etf:
Check out Virtus LifeSci Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note that the Virtus LifeSci Biotech information on this page should be used as a complementary analysis to other Virtus LifeSci's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.